A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence.
Carlos R V KifferThais F T RezendeDaniela Testoni Costa-NobreAna Sílvia Scavacini MarinonioLucas Hidemitsu ShiguenagaDebora Nicole Oliveira KulekLavinia Nery Villa Stangler ArendIvson Cassiano de Oliveira SantosBruna Ribeiro Sued-KaramClaudio Marcos Rocha-de-SouzaLeticia KraftAndre AbreuRenata Tigulini de Souza PeralAna Paula D'Alincourt Carvalho-AssefMarcelo PillonettoPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
This study shows the strengths of the AMR Brazilian Surveillance Network with robust data related to carbapenemases in Brazil and the impact of COVID-19 with a change in carbapenemase profiles with blaNDM rising over the years.
Keyphrases
- acinetobacter baumannii
- coronavirus disease
- pseudomonas aeruginosa
- multidrug resistant
- klebsiella pneumoniae
- drug resistant
- sars cov
- cystic fibrosis
- escherichia coli
- biofilm formation
- respiratory syndrome coronavirus
- gram negative
- public health
- risk assessment
- crispr cas
- quality improvement
- big data
- machine learning
- staphylococcus aureus
- antimicrobial resistance